Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RLIIX vs. SBIO: which is better?

Bottom line

RLIIX vs SBIO: the short answer

RLIIX (ALPS Asset Allocation Growth & Income) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds.

But SBIO is far broader, holding 89 positions to 15 for RLIIX, so beyond the top names it adds exposure RLIIX doesn't have.

SBIO is cheaper at 0.5% vs 0.55% — a difference of $5.00 a year per $10,000 invested.

Over five years, RLIIX returned +7.3% a year vs +0.7% for SBIO.

Updated Nov 19, 2026

RLIIX vs SBIO side by side

RLIIXSBIO
TypeMutual fundETF
Fund familyAmerican Funds (Capital Group)Alps
CategoryAllocation / BalancedHealth Care Sector
Expense ratio0.55%0.5%
Annual cost per $10k$55$50
10-yr cost on $10k (prospectus)$689$628
Max front load0%None
12b-1 fee0%—
1-yr return+14.6%+54.2%
5-yr return (annualized)+7.3%+0.7%
10-yr return (annualized)+7.2%+5.7%
Best quarter—+33.9%
Worst quarter—−30.8%
Net assets (fund)$76.4M$161.8M
Number of holdings1589
Portfolio turnover113%58%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

RLIIX and SBIO share none of their top holdings.

RLIIX top 10

  1. Alps Dynamic Us Dividend Advantage Etf — 19.59%
  2. Alps Active Equity Opportunity Etf — 19.34%
  3. Alps Strategic Income Fund — 12.54%
  4. Ishares Core Msci International Developed Markets Etf — 10.01%
  5. Vanguard Morningstar Total Stock Market Etf — 6.07%
  6. Ishares Core U.s. Aggregate Bond Etf — 5.26%
  7. Alps International Sector Dividend Dogs Etf — 5.07%
  8. Ishares Core S&p 500 Etf — 4.26%
  9. Alps Electrification Infrastructure Etf — 3.89%
  10. Vanguard Mortgage-backed Securities Etf — 3.64%

SBIO top 10

  1. Alkermes Plc — 4.48%
  2. Kymera Therapeutics Inc — 4.23%
  3. Celcuity Inc — 3.92%
  4. Mirum Pharmaceuticals Inc — 3.90%
  5. Spyre Therapeutics Inc — 3.68%
  6. Cg Oncology Inc — 3.35%
  7. Apogee Therapeutics Inc — 2.93%
  8. Xenon Pharmaceuticals Inc — 2.90%
  9. Travere Therapeutics Inc — 2.77%
  10. Dianthus Therapeutics Inc — 2.64%

FAQ

What is the difference between RLIIX and SBIO?
RLIIX (ALPS Asset Allocation Growth & Income) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds. But SBIO is far broader, holding 89 positions to 15 for RLIIX, so beyond the top names it adds exposure RLIIX doesn't have.
Which is cheaper, RLIIX or SBIO?
SBIO has the lower expense ratio (0.5%).
Should I own both RLIIX and SBIO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.